drugset / Trial / NCT06376942
A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy
Phase 2/3
Unknown
1050 enrolled
Post Graduate Institute of Medical Education and Research, Chandigarh
RandomizedParallel-groupQuadruple-blindPrevention
Summary
No study has examined the role of inhaled glycopyrrolate on mucus secretion. We hypothesize that nebulized glycopyrrolate will improve bronchoscopy procedure by effectively suppressing airway mucus secretion, thereby decreasing cough, and thus improving patient comfort during bronchoscopy. In this study, we aim to compare the efficacy of nebulized glycopyrrolate versus nebulized ipratropium in suppression of cough during flexible bronchoscopy.
Timeline
- Start
- 2024-04-24
- Primary completion
- 2025-04-25
- Completion
- 2025-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | 50 ug | Inhaled |
| Comparator | Ipratropium | Small molecule | 500 ug | Inhaled |
Indications
No indication recorded.